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ABSTRACT
Metabolomics is an emerging field that entails the detailed characterization of the ensemble
of metabolites produced by living organisms; subfields include drug metabolism and natural
environmental toxin production. The first part of the dissertation pursued metabolism of
glyceollins, i.e., isoflavones produced by soybeans that are potential cancer therapy agents. In
vivo glyceollin metabolites produced in rats were investigated by on-line Liquid ChromatographyElectrospray Ionization Tandem Mass Spectrometry. An odd-electron fragment ion at m/z 148,
formed in violation of the even-electron rule, and diagnostic of the glyceollin backbone, was
discovered. Based on this finding, a negative mode precursor ion scanning method was developed
to screen for glyceollins and their metabolites from biological samples. Products of both Phase I
and Phase II metabolism were identified, none of which have been previously reported. Sulfated
metabolites were confirmed by accurate mass measurement, while glucuronide conjugation was
confirmed by enzyme-assisted glucuronidation by rat liver microsomes. Intact GSH-glyceollin
conjugates were not observed, but breakdown products of the GSH pathway, i.e.,
cysteinylglyceine, cysteine, and acetylated cysteine, were identified as conjugates of oxygenated
glyceollins. The identification of GSH by-product conjugates was confirmed in product ion spectra
acquired in the negative mode (where peptide anions, and glyceollin-bearing cleaved peptide
portions were observed), as well as in the positive mode (where intact oxygenated glyceollin
fragments appeared without the initially-present peptide portion). Mass spectral evidence strongly

xiii

supports a metabolic pathway involving initial epoxidation of glyceollins followed by GSH
addition at the epoxidation site.
The second part of the dissertation undertook the investigation of secondary
metabolites called microbial volatile organic compounds (MVOCs) produced by fungi (mold) that
have been reported to have adverse human health effects. MVOCs were collected onto different
sorbent materials and analyzed by Thermal Desorption Analysis coupled with on-line Gas
Chromatography-Mass Spectrometry. Fungal MVOCs were characterized from various simulated
flooding conditions (brackish, freshwater, and saltwater) and different substrates (nutrient rich vs.
low nutrient) to determine diagnostic MVOCs. Ten fungi from simulated environments were
identified by genetic sequencing. Cladosporium sp. and Chaetomium sp. were cultivated and their
emitted MVOCs, 3-furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal, were proposed
as diagnostic indicators of these fungi.
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CHAPTER 1

SCREENING AND IDENTIFICATIN OF GLYCEOLLINS AND THEIR
METABOLITES BY ELECTROSPRAY IONIZATION TANDEM MASS
SPECTROMETRY WITH PRECURSOR ION SCANNING

Syeda S. Quadri, Robert E. Stratford, Stephen M. Boué, and Richard B. Cole
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1.1

Abstract

A method has been developed for screening glyceollins and their metabolites based upon
precursor ion scanning. Under higher-energy collision conditions employing a triple quadrupole
mass spectrometer in the negative ion mode, deprotonated glyceollin precursors yield a diagnostic
radical product ion at m/z 148. We propose this resonance-stabilized radical anion, formed in
violation of the even-electron rule, to be diagnostic of glyceollins and glyceollin metabolites.
Liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)
established that scanning for precursors of m/z 148 can identify glyceollins and their metabolites
from plasma samples originating from rats dosed with glyceollins. Precursor peaks of interest were
found at m/z 337, 353, 355, 417, and 433. The peak at m/z 337 corresponds to deprotonated
glyceollins, whereas the others represent metabolites of glyceollins. Accurate mass measurement
confirmed m/z 417 to be a sulfated metabolite of glyceollins. The peak at m/z 433 is also sulfated,
but it contains an additional oxygen, as confirmed by accurate mass measurement. The latter
metabolite differs from the former likely by the replacement of a hydrogen with a hydroxyl moiety.
The peaks at m/z 353 and 355 are proposed to correspond to hydroxylated metabolites of
glyceollins wherein the latter additionally undergoes a double bond reduction.
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1.2

Introduction

Soybean produces isoflavones that are known to have beneficial effects on human
health.1,2,3,4,5 In recent years, much research has been conducted on genistein, an isoflavone that
has been proposed to have anti-cancer activity.6,7,8 The potential chemopreventive effect of
genistein has prompted researchers to investigate soybean further for anticancer agents. A more
recently investigated type of isoflavones are the glyceollins that are produced by soybeans under
stressed conditions. The stressful conditions may include exposure to UV light, or fungal (e.g.,
Aspergillus) or bacterial pathogens.9 Because they are produced by a defense mechanism in
response to pathogen invasion, glyceollins may be referred to as phytoalexins.10
Glyceollins exist in three isomeric forms, Glyceollin I, II and III (Scheme 1.1). The
isomers are derived from a daidzein precursor through several intermediate steps.11 Among the
biological effects of glyceollins are potential human health benefits including anti-fungal, antioxidant, anti-inflammatory, anti-diabetic, and cancer cell anti-proliferative activity along with
other beneficial properties.12,13,14 Recently, many studies have proposed glyceollins as prevention
or therapy candidates for breast, ovarian, and prostate cancers. All three glyceollin isomers have
exhibited anti-estrogenic effects on estrogen receptor function and estrogen-dependent tumor
growth.

15, 16

Specifically, glyceollins bind to the estrogen receptor and they inhibit estrogen-

induced tumor progression of breast cancer (MCF-7) and ovarian cancer (BG-1) cells.16 Among
the three isomers, glyceollin I has the most potent anti-estrogenic activity.17,18 Another in vivo
study examining post-menopausal monkeys suggested glyceollins reduce breast cancer biomarker
expression.19 Human prostate cancer cell research demonstrated that glyceollins have multiple
effects on prostate cancer cells (LNCaP).20
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Scheme 1.1: Structures of Glyceollin isomers

The inhibition of prostate cancer cell growth by glyceollins is similar to that exhibited by
genistein, but the former also up-regulate cyclin-dependent kinase inhibitor and down-regulate
mRNA levels for androgen-responsive genes through androgen-mediated pathways.20 In addition
to the anti-estrogenic activity, glyceollins normalize glucose homeostasis and improve glucose
utilization in adipocytes.13,21 The anti-diabetic potential was also noted in prediabetic21 and Type
2 diabetic rats21 and mice..22 These potential benefits of glyceollins have been well documented,
but its metabolism is not well understood.23
Several mass spectrometric approaches that use various ionization techniques such as
electron ionization (EI), fast atom bombardment (FAB), thermospray (TSP), atmospheric pressure
chemical ionization (APCI), and electrospray ionization (ESI) have been used to investigate
flavonoids.24,25,26,27,28 Tandem mass spectrometry using low-energy collision-induced dissociation
4

(CID) to obtain structural information regarding mass-selected precursors has been shown to be
advantageous in characterizing flavonoids28 and was recently applied in the analysis of glyceollins
from soy bean extracts.29 Given the propensity for extensive metabolism of flavonoids following
their ingestion30 and that no research has addressed identification of glyceollins' metabolites in
animal systems, the significance of the present research is that it investigates glyceollins in plasma
and presents method development work designed for screening of glyceollins and glyceollinrelated metabolites.
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1.3
1.3.1

Experimental Methods

Extraction of Glyceollins isomers
A mixture of glyceollins I, II, and III was obtained using a procedure developed at the

Southern Regional Research Center (ARS, USDA, New Orleans, LA). Briefly, soybean seeds (1
kg) were sliced and inoculated with Aspergillus sojae. After 3 days, the glyceollins were extracted
from the inoculated seeds with 1 L methanol (Aldrich Chemical Co., St. Louis, MO). The
glyceollins were isolated using preparative scale HPLC using two Waters (Milford, MA) 25 x 100
mm, 10 µm particle size µBondapak C18 radial compression column segments that were combined
using an extension tube. HPLC was performed on a Waters 600E System Controller combined
with a Waters UV-Vis 996 detector scanning from 210-400 nm. Elution was carried out at a flow
rate of 8.0 mL/min with the following solvent system: A = acetonitrile (Aldrich Chemical Co.), B
= water (Millipore system, Billerica, MA) 5% A for 10 min, then 5% A to 90% A in 60 min
followed by holding at 90% A for 20 min. The injection volume was 20 mL. The fraction
containing the glyceollins was concentrated under vacuum and freeze-dried. Confirmation of
individual glyceollins was based on matching of HPLC retention times and matching of UV-Vis
absorbance spectra with those of authentic standards isolated at SRRC17. UV-Vis
spectrophotometry at 285 nm allowed an estimation of mixture contents used in all experiments:
glyceollin I (68%), glyceollin II (21%), and glyceollin III (11%).
1.3.2

Glyceollin dosing of rats and plasma sample collection
The administration of glyceollins to rats and subsequent sample collection have been

previously described.21 Briefly, glyceollins were dissolved in poloxamer to administer 90 mg/kg
via oral gavage (3 mL) to male ZDSD rats (PreClinOmics, Indianapolis, IN) that were housed in
a suspended wire cage and maintained on a 12:12 hr light-dark cycle. Three hr after administration,
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rats (approx. 500 g wt.) were euthanized at various time points by decapitation and trunk blood
was collected into EDTA-coated tubes supplemented with aprotinin. Plasma was separated and
stored at -80 ºC until analysis. Glyceollins were extracted for mass spectrometry analysis by
thawing the samples and transferring 125 µL of plasma into a microcentrifuge tubes. An equivalent
volume of acetonitrile was then added. The mixture was vortexed and centrifuged at 10,000 rpm
for 20 min. 100 µL of supernatant was transferred into a clean microcentrifuge tube for analysis.
1.3.3

Liquid Chromatography-Mass Spectrometry
LC-MS and LC-MS/MS analyses were conducted on an Agilent 1200 series LC system

(Agilent, Santa Clara, CA) coupled with a 3200 QTrap triple quadrupole mass spectrometer
(Applied Biosystems/MDS SCIEX, Foster, City, CA). Separation was performed on an Agilent
Eclipse - XDB C18 column (4.6 x 150 mm ID, 5 µm). 10 µL was injected onto the column held at
25 oC. Mobile phase A was water with 0.1% formic acid whereas mobile phase B was acetonitrile
with 0.1% formic acid. The gradient was 0-2 min 3% B, 2-7 min 3% to 60% B, 7-14 min 60% to
100% B, 14-20 min 100% B, 20-30 min 100% to 3% B. Flow rate was 0.500 mL/min. The UV
absorbance detector was set at 210 and 282 nm.
All mass spectrometry experiments were performed in the negative ion mode. For LC-ESIMS and LC-ESI-MS/MS analyses, electrospray parameters were set at: curtain gas 10 psi, ionspray
voltage -4000 V, GAS1 60 psi, GAS2 60 psi, source temperature 600 oC, CAD gas pressure 6 psi,
entrance potential -10 V, collision cell exit potential -3 V. Declustering potential and collision
energy were optimized to be -75 V and -34 eV, respectively. The information-dependent
acquisition (IDA) method was employed to perform full scan, tandem MS and precursor ion scans
sequentially (1 sec/scan).
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1.3.4

Direct Infustion ESI-MS
Direct infusion parameters were the same as above except for GAS1, GAS2 and source

temperature, which were set at 20 psi, 0 psi, and 50 oC, respectively. Samples were infused for 2
min at a flow rate of 4 µL/min. Direct infusion data was acquired using multiple-channel
acquisition (MCA).
1.3.5

Accurate mass measurements by ESI-FRICR-MS
Accurate mass measurements to determine metabolite empirical formulas were performed

on a Solarix 7T fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer (Bruker
Daltonics, Bremen, Germany). An ESI voltage of 4500 V was used with 2 Bar nebulizer gas
pressure; drying gas was delivered at 4 L/min and 200 °C drying temperature. Peaks at m/z 113,
432, and 602 from ESI Tuning Mix (Agilent Technologies, Santa Clara, CA) were used as internal
standards in mass spectra consisting of 40 averaged acquisitions.
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1.4
1.4.1

Results and Discussion

Collision-Induced Dissociations of Glyceollins
Isomeric glyceollin I, II, and III standards and plasma samples obtained from rats dosed

with glyceollins were analyzed and characterized by negative ion MS and tandem MS. [M-H]peaks corresponding to deprotonated forms of glyceollin isomers were observed at m/z 337. Lowenergy CID of these [M-H]- precursors (Figure 1-1) produced product ion peaks similar to those
reported by Gruppen et al.29 For instance, m/z 319, 215, 187, 175, 161, 149 were all present in high
abundances. In addition, low abundance peaks reported by Gruppen et al.29 (m/z 322, 309, and
293) were also observed. Surprisingly, under higher-energy conditions in the negative ion mode,
a previously unreported CID peak emerged at m/z 148 with such a strong signal that it became the
base peak in the product ion spectrum (Figure 1-1).31 We attribute the dominance of this openshell fragment in the product ion mass spectrum of glyceollins to its exceptional stability as
supported by the extensive delocalization of both the charge and the radical over the aromatic ring
system (see inset, Figure 1-1). Indeed, fragmentation to form this product constitutes a violation
of the even-electron rule,32 i.e., normally formation of a radical product ion plus a radical neutral
is forbidden from decompositions of an even-electron precursor. However, homolytic cleavage of
even-electron ions has been documented to occur especially in cases where exceptional stability is
acquired by the formed radical ion and radical neutral. 32,33,34,35 Because the m/z 148 product ion
is formed from the portion of the molecule that is conserved in all of the glyceollin isomers, we
propose to use the appearance of this unique radical ion in MS/MS spectra as a product ion
diagnostic of all glyceollins.31 Thus, the presence of this product ion can be used as a signature to
identify glyceollins and their related metabolites. As a single caveat, in cases where the D or B
rings become modified, the m/z 148 ion could be shifted to another even m/z value with a possible
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decrease in intensity. Notably, this product ion was also observed during low-energy sustained offresonance irradiation (SORI) - CID in a FT-ICR. The empirical formula (C8H4O3) of the resonance
stabilized m/z 148 ion was confirmed by accurate mass measurement.

-MS2 (337.10) CE (-30): 111 MCA scans from Sample 3 (Glyceollin I + Bicarbonate, NI, MS2) of Glyceollin I.wiff (Turbo Spray)
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Figure 1-1: Negative ion electrospray product ion mass spectrum (-75 eV CID )
of [M-H]- precursor of glyceollin (m/z 337). Under these higher-energy conditions, the
product ion at m/z 148 appears in high abundance.
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1.4.2

Optimization of CID conditions
CID conditions for the triple quadrupole, including the “declustering potential” (V, also

known as nozzle-skimmer potential) and the collision energy (eV, Elab) were serially adjusted to
maximize the intensity of the diagnostic product ion at m/z 148 formed from glyceollin [M-H]precursors. Other MS conditions such as ion spray voltage, curtain, nebulizing and turbo gases
were maintained at constant values (see Experimental section). The declustering potential value
for precursor m/z 337 was optimized (by ramping up its voltage) to obtain the highest intensity of
m/z 148 in product ion mode. The optimum declustering potential yielding the maximum intensity
of m/z 148 was -75 V. Tandem MS of m/z 337 was then performed using a fixed declustering
potential of -75 V, while ramping up the collision energy. The highest signal for m/z 148 was
observed at an Elab value of -34 eV. Figure 1-2 shows the automated infusion “quantitative
optimization” of the declustering potential (Figure 1-2a, m/z 148 only) and Elab (Figure 1-2b, 3
highest intensity fragments: m/z 148, m/z 149 and m/z 319). The breakdown curves shown in Figure
1-2b clearly indicate that upon decomposition of m/z 337, m/z 149 has a lower appearance energy
than m/z 148. This finding can be rationalized by considering that for these closely related
fragments, production of even-electron m/z 149 (with formation of an additional carbon-hydrogen
bond and resulting stabilization) requires less energy than formation of odd- electron m/z 148.
However, as the internal energy uptake is increased, the rate constant of m/z 148 formation
becomes more favorable and the curves for formation of the respective products cross (Figure 12b inset). This curve-crossing is a classic example36,37 of competitive ion formation where the
fragment with the lower appearance threshold dominates under lower energy collisions (e.g.,
conditions used by Gruppen et al.29, m/z 149 is favored), whereas the fragment formed by the
higher frequency factor32 process dominates at higher collision energies (m/z 148, see Figure 1-1).
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m/z 148
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Rate

m/z 149

m/z 149

Internal Energy of m/z 337
m/z 319

Figure 1-2: (a) The optimum declustering potential value to produce m/z 148
from CID of m/z 337 precursors was determined by ramping the declustering potential
in product ion mode. The maximum intensity of m/z 148 was observed at -75 V. (b)
Optimization of collision energy for m/z product ion formation at fixed declustering
potential of -75 V. Abundances of three strong peaks: m/z 148, 149, 319 are shown as a
function of collision energy. The highest signal for m/z 148 was observed at -34 eV (Elab).
The inset schematically shows the rates of formation of m/z 148 and 149 as a function of
internal energy of m/z 337.
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1.4.3

Precursor Ion Scan of m/z 148
Upon optimization of CID conditions, m/z 148 was observed as the base peak in the

product ion mass spectra of [M-H]- precursors from each purified standard of glyceollin I, II, and
III. To follow through on the idea of using m/z 148 as a diagnostic product ion for glyceollins, the
above optimized CID conditions maximizing m/z 148 production were used to obtain precursor
ion scans of m/z 148 using glyceollin mixtures. As expected, [M-H]- at m/z 337 was detected in
high intensity, thus confirming that precursor ion scans of the diagnostic radical m/z 148 can be
used to detect glyceollins and glyceollin related compounds. In principle, one could also consider
using m/z 149 for precursor ion scans, but in practice, this would be a poor choice because a wide
variety of phtahlate esters (ubiquitous plasticizers) produce m/z 149 upon ESI-MS/MS.38

1.4.4

LC-ESI-MS and LC-ESI-MS/MS analyses of glyceollins and their metabolites in rat

plasma
To test the validity of this method to identify glyceollins and their metabolites, it was
applied to the analysis of plasma samples derived from rats dosed with glyceollins. For these LCESI-MS and LC-ESI-MS/MS experiments, the MS data acquisition method cycled through a full
MS scan, a CID precursor ion scan of m/z 148, and a CID product ion spectrum of m/z 337. Once
the precursors of m/z 148 were identified, in subsequent runs, the CID product ion scans of those
precursors were added to the acquisition scan cycle. In a plasma sample taken at 20 min following
a 90 mg/kg dose of glyceollins, the precursor ion scan of m/z 148 showed eluting peaks at 10.5
and 12.5 min (Figure 1-3a). The peak at 12.5 min corresponds to (unmetabolized) deprotonated
glyceollins (m/z 337) as shown in the averaged mass spectrum corresponding to this
chromatographic peak (Figure 1-3 inset). The earlier eluting peak (10.5 min) corresponds to an
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apparent metabolite of glyceollins which gave a base peak at m/z 417 (Figure 1-3 inset). Notably,
the employed CID conditions produced enough internal energy uptake to cause consecutive
decomposition of this metabolite to produce m/z 337 (deprotonated glyceollins). In a different rat
plasma sample taken at 4 hrs following the dose of glyceollins (90 mg/kg), precursor ion scanning
of m/z 148 resulted in the appearance of glyceollin metabolites eluting at 3.9, 4.2 and 9.6 min
(Figure 1-4). These chromatographic peaks correspond to metabolites of m/z 451, 433, and 417,
respectively (see inset Figure 1-4). Again, consecutive decomposition of the m/z 417 metabolite
was observed to produce m/z 337. It appears that metabolism was extensive in this case because
unmodified glyceollins were not detected in this sample.
XIC of -Prec (148.20): Exp 2, 148.0 to 600.0 amu from Sample 21 (Sample 126, LC method: glyceollin 40-60) of LC-MS Glyceollin.wiff (...
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Figure 1-3: LC-MS/MS precursor ion scans showing total ion current of all precursors of
m/z 148 from glyceollins dosed rats. The insets show the precursor ion spectra of m/z 148
averaged over the width of the peaks eluting at 10.5 and 12.5 min showing the presence of
a metabolite and unmetabolized glyceollins, respectively.
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Figure 1-4: LC-MS/MS precursor ion scan showing total ion current of all precursors of
m/z 148 from glyceollins dosed rat plasma. Inset are the averaged mass spectra obtained
across the three observed chromatographic peaks.
1.4.5

Identification of glyceollins’ metabolites using LC-ESI-MS and LC-ESI-MS/MS
The CID product ion spectrum of the m/z 417 precursor (Figure 1-5) shows many of the

same fragments as observed in the CID product ion spectrum of m/z 337 (Figure 1-1). In
considering the mass increase of this metabolite, in general, an addition of 80 Da in a biological
medium may correspond to either a sulfation or a phosphorylation process. The metabolism of
glyceollins in the digestive tract is not well documented23 and to our knowledge there have not
been any reports of glyceollins’ metabolites. However, another isoflavone, genistein, has been
extensively studied, and it has been reported to undergo phase II metabolism by glucuronidation,
sulfation, and methylation in small intestine and liver.30,39,40 Based on these reports of genistein
metabolism, and interpretation of the obtained CID spectrum of m/z 417 (Figure 1-5), the peak was
tentatively assigned as the sulfated metabolite of glyceollins. However, because m/z 417 could
correspond to either the sulfated or the phosphorylated metabolite (deprotonated forms), to
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Figure 1-5: LC-MS/MS product ion mass spectrum of m/z 417 precursors from rats
dosed with glyceollins. The m/z 417 metabolite was assigned as a sulfated form of
glyceollins.
definitively identify m/z 417, accurate mass analysis was performed on this ion. The
addition of a phosphate group implies a molecular formula of C20H18O8P with an exact m/z of
417.074478, whereas sulfated glyceollins have the molecular formula C20H17O8S with an exact
m/z of 417.064962. The accurate mass measurement by FT-ICR gave m/z 417.064812 confirming
the assignment of m/z 417 as a sulfated metabolite of glyceollins (0.360 ppm error). Because the
CID product ion spectrum of m/z 417 (Figure 1-5) shows similar fragments as the CID product ion
spectrum of m/z 337 (Figure 1-1), and because there are no fragment ions that are shifted by 80
m/z units in the former spectrum relative to the latter, we conclude that the sulfate group is the
most labile moiety of the m/z 417 metabolite. Thus, the first step in decompostion of m/z 417 is
loss of SO3 neutral to form deprotonated glyceollins at m/z 337. All of the lower m/z fragments in
Figure 1-5 are proposed to be formed by consecutive decompositions of m/z 337. Notably, at the
constant Elab collision energy (- 34 eV) employed throughout this paper, energy is consumed in
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the decomposition of m/z 417 leading to m/z 337. The m/z 337 ions thereby formed have less
internal energy available to induce consecutive decompositions as compared to m/z 337 precursors
that are subjected directly to -34 eV collisions in the central quadrupole. This loss of internal
energy in the first step of decomposition results in more favorable kinetics for m/z 149 formation
as compared to m/z 148 (see Figure 1-2b inset) in consecutive decompositions.
The hydroxyl sites of glyceollins are preferred sites of sulfation. We assign sulfation to the
hydroxyl site of the phenol group (see inset, Figure 1-5) based upon the observed facile loss of
SO3 neutral which, in this case, leaves a resonance stabilized phenoxy anion (corresponding to
deprotonated glyceollins at m/z 337). The loss of SO3 neutral from glyceollins sulfated at the alkyl
hydroxide would be expected to be less favorable. As glyceollins are known to exhibit competitive
behavior with estrogens, this assignment is supported by the documented preferential sulfation of
the 3-phenolic hydroxyl relative to the 16-aliphatic hydroxyl in estriol.41
Another metabolite appearing in Figure 1-4 (retention time 4.2 min corresponding to m/z
433) was investigated further. The composition of m/z 433 was established to be C20H17O9S by
accurate mass measurement (m/z 433.059649, 0.524 ppm error). This peak at m/z 433 is proposed
to correspond to a (deprotonated) sulfated metabolite of glyceollins that contains one additional
oxygen relative to m/z 417 discussed above. The LC-ESI-MS/MS low-energy CID product ion
spectrum of the m/z 433 precursor (Figure 1-6) reveals the B fragment peaks (m/z 148, 149) to be
the same as those in the product ion spectrum of deprotonated glyceollins (m/z 337, Figure 1-1)
whereas A fragments are shifted by 16 m/z units (i.e., m/z 175 and 227 are shifted to 191 and 243,
respectively), plus m/z 337 is shifted to 353. This different behavior of A and B fragments allows
us to narrow down the potential sites of hydrogen replacement with a hydroxyl group that accounts

17

for the 16 Da shift in the mass of the metabolized molecule. All possible hydroxylation sites are
marked with asterisks on the structure of m/z 433 shown in Figure 1-6.
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433

100%
*
*

90%

R e l. In t . ( % )

Relative Intensity (%)

**
O

O
OH

**

80%

* *
*O *

70%

O

353

*
*

O

**
O

O

A

**

O

C

OH

D
O

**

60%

B

O
O S O
O

191

50%

* *
*O *

40%
O

30%

m/z 433
O

**

O

O

243

O

O

20%

O

O

10%

Max. 1.6e4 cps.

148149

100

200

300
m/z, amu

400

500

600

Figure 1-6: Negative ion low-energy CID product ion mass spectrum of m/z 433 from rats
dosed with glyceollins. Potential sites of replacement of a hydrogen with a hydroxyl group
are marked with asterisks. The labeling of the ring system has been adopted from Gruppen
et al.29
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1.4.6

Screening of glyceollins’ metabolites by direct infusion
LC separation prior to ESI-MS or ESI-MS/MS analyses offers the theoretical advantage

that each analyte species may enter the ESI source of the mass spectrometer free from
interferences. Even so, the sequential isolation and analysis steps of tandem mass spectrometry
can enable direct mixture analyses in the absence of chromatographic separation. When very
complex mixtures are under investigation, however, analyte desorption behavior may be affected
by competing sample species. It is well documented that in ESI-MS, surface-active species tend
to be desorbed most efficiently, whereas the less surface-active molecules tend to experience signal
suppression.42 To compare the performance of our precursor ion scanning approach in the presence
and absence of chromatographic separation, the same rat plasma mixture as used above was
employed, except that this time precursor ion scans of m/z 148 were performed directly on the
complex mixture with no prior LC separation. Direct infusion of the acetonitrile extracts of a rat
plasma mixture resulted in the detection of m/z 148 precursor ions at m/z 337, 353, 355, 417, 433,
451, and 469 (Figure 1-7). The peak at m/z 337 once again represents unmetabolized deprotonated
glyceollins. The peaks at m/z 417 and 433 were previously assigned as the sulfated metabolite of
glyceollins, and the sulfated metabolite of glyceollins with one additional oxygen, respectively. It
is fair to say that neither the m/z 417 nor the m/z 433 signal was suppressed during ESI-MS/MS
direct mixture analysis. This may be rationalized by considering that the sulfated conjugates of
glyceollins have substantial surfactant character, which can explain the favorable signal response
relative to other components of the complex mixture.
Notably, peaks at m/z 353, 355, and 469 were detected in direct infusion mixture analysis
that were absent in LC-ESI-MS/MS. The precursor peaks at m/z 353 and 355 are most likely
hydroxylated metabolites of glyceollins, wherein the latter contains an additional reduced double
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bond. The improved detectability in direct infusion ESI-MS/MS may be rationalized if one
considers the additional acquisition time afforded by direct infusion that serves to improve signalto-noise (S/N) ratios. Moreover, in LC-MS/MS experiments, the (S/N) ratios may not be
maximized if spectra are averaged across the entire width of the chromatographic peak (due to
weaker signals away from the center of the peak).43 A literature example reports a 20-fold gain in
sensitivity observed with direct infusion of LC fractions using multichannel acquisition, as
compared to LC/MS.44 Therefore, we suspect that the conditions employed for LC-ESI-MS/MS
resulted in a detection limit just above the threshold for observation of these m/z 353, 355, and 469
signals.
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Figure 1-7: Direct infusion negative ion electrospray -75 V CID precursor ion scan of
m/z 148 from rat plasma derived from rats.
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1.5

Conclusion

A precursor ion scan method based on m/z 148 product ion formation was developed and
optimized to screen for glyceollins and glyceollin related compounds, including metabolites. LCESI-MS/MS analyses with both precursor ion and product ion scans were carried out on a triple
quadrupole to identify glyceollins and their metabolites in rat plasma. Precursor ion scanning of
m/z 148 allowed the characterization of glyceollins’ metabolites at m/z 417, 433, 353, and 355.
After inspection and interpretation of obtained tandem mass spectra, accurate mass measurements
of m/z 417 and 433 were performed, thus, confirming the in vivo sulfation, and sulfation plus
oxygen addition, respectively, of glyceollins in rats. In addition, metabolites at m/z 353 and 355
were observed and were proposed to represent hydroxylated forms of glyceollins wherein the latter
has one less double bond. Along with developing a method to screen for glyceollins and its related
compounds, this study is the first to establish hydroxylation and sulfation metabolic pathways of
glyceollins in dosed animals.
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CHAPTER 2

IDENTIFICATION OF GLYCEOLLIN METABOLITES DERIVED FROM
CONJUGATION WITH GLUTATHIONE AND GLUCURONIC ACID IN
RATS BY ON-LINE LIQUID CHROMATOGRAPHY-ELECTROSPRAY
IONIZATION TANDEM MASS SPECTROMETRY

Syeda S. Quadri, Robert E. Stratford, Stephen M. Boué, and Richard B. Cole
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2.1

Abstract

Glyceollin-related metabolites produced in rats following oral glyceollin administration
were screened and identified by precursor and product ion scanning using liquid chromatography
coupled on-line with electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).
Precursor ion scanning in the negative ion (NI) mode was used to identify all glyceollin metabolites
based on production of a diagnostic radical product ion (m/z 148) upon decomposition. Using this
approach, precursor peaks of interest were found at m/z 474 and 531. Tandem mass spectra of
these two peaks allowed us to characterize them as by-products of glutathione conjugation. The
peak at m/z 474 was identified as the deprotonated cysteinyl conjugate of glyceollins with an
addition of an oxygen, whereas m/z 531 was identified as the deprotonated cysteinylglyceine
glyceollin conjugate plus an oxygen. These results were confirmed by positive ion (PI) mode
analyses. Mercapturic acid conjugates of glyceollins were also identified in NI mode as
deprotonated molecules at m/z 500. In addition, glucuronidation of glyceollins was observed,
giving a peak at m/z 513 corresponding to the deprotonated conjugate. Production of glucuronic
acid conjugates of glyceollins was confirmed in vitro in rat liver microsomes. Neither glutathione
conjugation by-products nor glucuronic acid conjugates of glyceollins have been previously
reported.
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2.2

Introduction

Cancer is the second leading cause of death in the United States after heart disease,1 yet
there is still no cure for this disease. Soybean isoflavones have been shown to exhibit anti-cancer
and anti-proliferative activity toward cancerous cells.2,3 Much of the research concerning
isoflavones has been conducted on diadzein and genistein.4-8 Among the more recently studied
isoflavones are the glyceollins that are also produced by soybeans under stressed conditions (e.g.,
UV light exposure or infection by Aspergillus).9,10 Glyceollins, like other soy isoflavones, are nonsteroid compounds that have diphenolic groups which closely resemble the steroid structure of
estradiol.11 Several propositions have been offered to explain the mechanism of inhibition of
cancer by soy isoflavones through antiestogenic activity by interfering cancer cells’ ability to
respond to estradiol.10,17
Recent investigations have proposed glyceollins as prevention or therapy candidates for
breast, ovarian, and prostate cancers.12,17 Glyceollins exhibit anti-estrogenic effects on estrogen
receptor function and estrogen-dependent tumor growth.13,14 Breast cancer (MCF-7) and ovarian
cancer (BG-1) cell proliferation, which is induced by estrogen, was found to be inhibited by
glyceollins.15 Furthermore, studies conducted on post-menopausal monkeys and human prostate
cancer cell line (LNCaP) also showed a reduction in cancer progression by glyceollins.16,17 The
potential anticancer benefits of glyceollins have been well documented, but its metabolism is not
well understood18 other than the evidence for sulfation.19
Typically, drugs are eliminated or detoxified from the body through phase I and II
metabolism.20 Phase I results in oxidation, reduction, or hydrolysis of a drug.21,22 Phase II
conjugation is a common pathway for isoflavone metabolism which results in methylation,
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sulfation, glucuronidation, and glutathione conjugation.23,24,25 Some of the metabolic pathways that
are involved in drug detoxification, in particular glutathione conjugation, have been shown to
promote drug resistance and/or additional adverse health effects during cancer treatment.26
Therefore, it is extremely important to have a thorough understanding of metabolic pathways.
Metabolism of genistein has been well studied and it is known to undergo sulfation and
glucuronidation,27,28,29 but much less is known about glyceollins metabolism. A recent study
conducted on rats reported absorption of glyceollins across the gastrointestinal tract of rats.
Maximum plasma concentrations of 160 ng/ml were attained in rats within 4 hr of oral
administration of a single dose of 90 mg/kg.30 The current in vivo study builds upon our previous
identifications of sulfated metabolites of glyceollins found in rat plasma19 by investigating
glyceollin metabolites in rat plasma and feces.
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2.3
2.3.1

Experimental Method

Extraction of glyceollin isomers
Using a procedure developed at the Southern Regional Research Center (ARS, USDA,

New Orleans, LA), a mixture of glyceollins I, II, and III was obtained. Briefly, after slicing,
soybean seeds (1 kg) were inoculated with Aspergillus sojae. Three days later, the glyceollins
were extracted from the inoculated seeds with 1 L methanol (Aldrich Chemical Co., St. Louis,
MO). The glyceollins were isolated using preparative scale HPLC employing two Waters
(Milford, MA) 25 x 100 mm, 10 µm particle size µBondapak C18 radial compression column
segments; the column segments were combined using an extension tube. HPLC was performed
on a Waters 600E equipped with a Waters UV-Vis 996 detector scanning from 210-400 nm. The
injection volume was 20 mL; the flow rate was 8.0 mL/min using the following solvent gradient:
A = acetonitrile (Aldrich Chemical Co.), B = water (Millipore system, Billerica, MA) 5% A for
10 min, then 5% A to 90% A in 60 min followed by holding at 90% A for 20 min. The fraction
containing the glyceollins was concentrated under vacuum and freeze-dried. Confirmation of
individual glyceollins was based on HPLC retention time and UV-Vis absorbance spectra
comparison with those of authentic standards isolated at SRRC. UV-Vis spectrophotometry at 285
nm was used to estimate the percentage of the three isomers used in all experiments: glyceollin I
(68%), glyceollin II (21%), and glyceollin III (11%).
2.3.2

Glyceollin dosing of rats and plasma sample collection
The procedures used for administration of glyceollins to rats and subsequent sample

collection have been previously described.31 Briefly, glyceollins dissolved in poloxamer were
administered (90 mg/kg) via oral gavage (3 mL) to male ZDSD rats (PreClinOmics, Indianapolis,
IN) that were subjected to a 12:12 hr light-dark cycle. Rats (approx. 500 g wt.) were euthanized
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at various time points by decapitation; trunk blood was subsequently collected into EDTA-coated
tubes supplemented with aprotinin. Plasma was separated and stored at -80 ºC. Upon thawing,
125 µL of plasma was transferred into microcentrifuge tubes to which an equivalent volume of
acetonitrile was added. The mixture was vortexed, then centrifuged at 10,000 rpm for 20 min. The
supernatant was subjected to mass spectrometric analysis.
2.3.3

Urine sample treatment
A urine sample obtained from a 24 hr collection period that commenced following a single

90 mg/kg oral dose to a rat was acidified with 1% TFA, vortexed, and centrifuged at 10,000 rpm
for 10 min. The supernatant was diluted with 1:1 0.2% formic acid in 10% acetonitrile and stored
at -80 oC until ready for LC-MS analyses.

2.3.4

Fecal sample collection
Feces from rats were collected prior to, and after the dosage of glyceollins (90 mg/kg). In

the latter case, samples were obtained following 2-weeks of once-daily dosing. Both the pre- and
post-dosed fecal pellets were weighed and a 1:2 (pellet weight: vol) ratio of deionized water was
added to each group. A smooth paste was created in a glass mortar and pestle. The paste was then
transferred to a polypropylene tube and diluted with CH3CN 1:2 (paste wt: vol). The tubes were
centrifuged for 5 min at 1000 rpm. Supernatant was collected and transferred to fresh tubes; then
approximately 0.1 g of ammonium acetate was added progressively with gentle vortexing. Tubes
were subsequently centrifuged for 5 min at 1000 rpm. The supernatant (acetonitrile layer) was
collected and stored at -70 oC until analysis.
2.3.5

Liver Microsomes treatment with UDPGA cofactor
Samples were prepared in triplicate for both the control and the experimental group. 134

µL of KH2PO4 buffer, 20 µL of 20 mg/mL rat liver microsomes, and 4 µL of 5 mg/mL alamethicin
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was added to 1.5 mL eppendorf tubes, vortexed, and incubated for 15 min. 20 µL of MgCl2 and 2
µL of 1 mM substrate were then added, vortexed and incubated for 3 min. 20 µL of KH2PO4 buffer
and 20 µL of 10 mM UDPGA were added to control and experimental groups, respectively. The
tubes were incubated for 60 min at 37 oC. 200 µL of cold acetonitrile was added to each tube to
terminate the incubation. Tubes were then vortexed followed by centrifugation for 5 min at 4000
rpm. Supernatant was transferred to fresh tubes and stored at -70 oC until analysis.

2.3.6

Liquid Chromatography-Mass Spectrometry
LC-ESI-MS and LC-ESI-MS/MS analyses were conducted on an Agilent 1200

series LC system (Agilent, Santa Clara, CA) coupled to a 3200 QTrap triple quadrupole mass
spectrometer (Applied Biosystems/MDS SCIEX, Foster, City, CA). Separation was performed on
an Agilent Eclipse - XDB C18 column (4.6 x 150 mm ID, 5 µm). 10 µL was injected onto the
column held at 25 oC. The binary mobile phase consisted of mobile phase A (water with 0.1%
formic acid) and mobile phase B (acetonitrile with 0.1% formic acid). The gradient was 0-104 min
5% B to 100% B. Flow rate was 0.500 mL/min. The UV absorbance detector was set at 285 nm.
For negative ion LC-ESI-MS and LC-ESI-MS/MS analyses, electrospray
parameters were set at: curtain gas (CUR) 20 psi, ionspray voltage (IS) -4500 V, GAS1 60 psi,
GAS2 60 psi, source temperature 600 oC, CAD gas pressure 6 psi, entrance potential (EP) -10 V,
collision cell exit potential (CXP) -3 V. Declustering potential (DP) and collision energy (CE)
were optimized to be -55 V and -34 eV, respectively. For positive ion experiments, CUR, IS, EP,
CXP, DP and CE were maintained at 10 psi, 5000 V, 10 V, 5 V, 40 V, and 30 eV, respectively.
All other parameters were the same as for negative ion mode. The information-dependent
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acquisition (IDA) method was employed to perform full scan and precursor ion scans sequentially
(scan rate = 1 sec/200 Da). Tandem spectrometry was then carried out on precursors of interest.
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2.4
2.4.1

Results and Discussion

Precursor ion scans of m/z 148
In our previous work, we proposed a precursor ion scan method to screen for isomeric

glyceollins and their metabolites based on a diagnostic radical product ion.19,32 The high energy
CID product ion spectrum of glyceollins yields an exceptionally stable radical at m/z 148, which
serves as a “signature” common to all three glyceollins isomers.19 Employing this negative ion
developed methodology based upon scanning for precursors of m/z 148, plasma and feces samples
from rats dosed with isomeric glyceollins I, II, and III were screened for the glyceollins and their
metabolites by LC-ESI-MS and LC-ESI-MS/MS. The precursor ion scanning of m/z 148 for rat
feces samples resulted in the appearance of many more metabolites compared to rat plasma
samples. Figure 2-1 shows a representative LC chromatogram of a rat feces sample. All three
unmetabolized isomers of glyceollins (m/z 337) were detected. Peaks labeled 9, 8 and 10 on the
LC chromatogram correspond to glyceollin I, II, and III, respectively.
Little is known about glyceollins metabolism, but our findings from rat feces indicate that
extensive oxidation of glyceollins has occurred. Peaks 5, 1, and 6 represent m/z 148 precursors at
m/z 353, 371, and 387, respectively. Relative to deprotonated glyceollins (m/z 337), these three
metabolites are proposed as products of epoxidation and/or OH/H replacment of glycoleollins (m/z
353); diol addition at a double bond (m/z 371), , and a combination of the two processes above,
i.e., diol addition at a double bond plus epoxidation and/or OH/H replacment (m/ 387). Two of the
three above-mentioned peaks observed in rat feces (m/z 371, 387) were also detected in rat urine,
as was m/z 451 (the latter likely represents glyceollins that are both hydrolyzed and sulfated). The
above peaks were only observed in rat feces. LC-ESI-MS/MS precursor ion scanning of m/z 148
from rat feces showed additional peaks eluting at 14.4, 16.8, 19.3, 30.9, and 35.3 min. These
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chromatographic peaks correspond to glyceollins metabolite precursors at m/z 531, 474, 433, 417,
along with deprotonated glyceollins at m/z 337, respectively. These latter five precursors of m/z
148 were also found in rat plasma, whereas m/z 531 and 474 were observed from rat urine (data
not shown). Sulfation and sulfation plus an oxygen of glyceollins account for the peaks observed
at m/z 417 (peak 7) and 433 (peak 4), respectively, as discussed previously.19 Two remaining
precursor peaks of interest appear at m/z 474 and 531. These were considered as phase II
metabolites of glyceollins and were further investigated by tandem mass spectrometry as discussed
in the following section.

TIC of -Prec (148.00): from Sample 62 (LC-Prec 148, 5-60 in 60 min ) of Metabolomics Rat Feces.wiff (Turbo Spray), Smoothed, Smoot...
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Figure 2-1: LC-ESI-MS/MS precursor ion scans showing total ion current of all precursors of
m/z 148 from feces of rats dosed orally once-daily for two weeks with 90 mg/kg of the
glyceollin isomeric mixture.
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2.4.2

Identification of Glyceollins’ metabolites by LC-ESI-MS and LC-ESI-MS/MS
A chromatographic peak corresponding to the m/z 531 precursor from feces samples eluted

at 14.4 min (Figure 2-1) and an identical peak was also observed from rat plasma. The NI mode
LC-ESI-MS/MS CID product ion mass spectrum of this m/z 531 precursor (Figure 2-2a) from
feces summed across the entire chromatographic peak showed a fragment at m/z 353, which
corresponds to a loss of 178 Da. Appearing in Figure 2-2b is the NI mode LC-ESI-MS/MS CID
product ion mass spectrum of m/z 474 corresponding to a chromatographic peak eluting at 17.0
min (Figure 2-1). Similar to the result shown in Figure 2-2a, the m/z 474 also yields a fragment at
m/z 353, indicating this time, a loss of 121 Da. The combined information extracted from Figures
2.2a and 2.2b point to the deduction that glutathione conjugation has occurred to glyceollins and
that subsequent metabolic by-products of glutathione breakdown are present in both the rat feces
and plasma samples. We propose that the loss of 178 Da (Fig. 2.2a) corresponds to departure of
intact cysteinylglycine from the m/z 531 precursor that corresponds to a cysteinylglyceine
conjugate of an oxygenated form of glyceollins. Strongly supporting this proposition is the
appearance of a cysteinyl-glycine fragment ion at m/z 143 (Fig. 2.2a). To complement this
information, the 121 Da loss from the m/z 474 precursor (Fig. 2.2b) is proposed to correspond to
intact cysteine loss from the cysteinyl conjugate of oxygenated glyceollins. Further evidence to
support this assignment is given by the appearance of m/z 387 that corresponds to decomposition
of the cysteine amino acid (Fig. 2.2b).
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Figure 2-2: LC-ESI-MS/MS product ion spectrum of: (a) m/z 531 precursor and (b) m/z
474 precursor in negative ion mode. One site of hydroxylation and one site of peptide
addition is shown; Scheme 1 shows other possible isomeric structures.
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To further support these structural assignments, we consider that isoflavones are generally
biotransformed into metabolites with increased water solubility compared to the original forms in
order to facilitate excretion from the body. The major pathway through which these isoflavones
are converted into metabolites is through phase II metabolism. Among the various detoxification
mechanisms of drugs, the glutathione (GSH) metabolic pathway plays a major role in phase II
detoxification.34 GSH, consisting of glutamine (glu), cysteine (cys), and glycine (gly) amino amino
acids.33,34 forms conjugates with drugs and other xenobiotics with the assistance from Glutathione
S-transferases (GSTs).35 The first step of GSH breakdown, even when conjugated, involves
hydrolysis of the γ-glutamyl bond by γ-glutamyltranspeptidase to form glutamic acid and
(conjugated) cysteinylglycine; the cysteinylglycine can be further broken down into glycine and
(conjugated) cysteine.36,37 The cysteine conjugates can then be further metabolized via acetylation
of the N-terminal amine of cysteine to form mercapturic acid conjugates.38
The glyceollin metabolites detected in rat plasma, urine and feces appear to have undergone
glutathione conjugation. Although NI mode LC-ESI-MS/MS CID product ion mass spectra of
potential m/z 660 and 644 precursors (corresponding to oxygenated and non-oxygenated GSHglyceollins, respectively) were acquired from rat plasma, urine, and feces samples, no intact
glutathione conjugates of glyceollins were found. This can be attributed to the fast kinetics of
enzymatic glutamine cleavage from GSH-glyceollins complex that results in cysteinylglyceine
conjugates of glyceollins (m/z 531, Figure 2-2a). As mentioned above, cysteinylglyceine
conjugates are subsequently broken down into cysteine conjugates. The product ion spectrum of
the m/z 474 precursor (Figure 2-2b) corroborates the presence of cysteinyl conjugates of
glyceollins. These proposed metabolites are observed in oxygenated forms, i.e., in addition to the
cysteinyl sulfur linkage, an oxygen atom has been added. We propose that the addition of oxygen
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(Phase I metabolism) facilitates the subsequent addition of GSH (Phase II metabolism). Enzymatic
formation of epoxides followed by glutathione conjugation has been well documented.39,40
Epoxide formation at a double bond leads to a reactive intermediate that is highly susceptible to
GSH complex formation. There are four possible 1,2-addition products (Scheme 2.1).
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Scheme 2.1: Glutathione conjugation to two most favorable epoxide forms of glyceollin I.
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The CID product ion mass spectra of m/z 531 (Figure 2-2a) and 474 (Figure 2-2b) each
yield a fragment at m/z 353 corresponding to the loss of cysteinylglycine or cysteine, respectively,
with abstraction of a neighboring hydrogen and double bond (or epoxide) formation on the
glyceollins in each case. In addition, Figures 2.2a and 2.2b each show the presence of m/z 149, i.e.,
the B fragment ion formed from decomposition of the glyceollin backbone.19 In our previous study,
the CID product ion spectrum of the sulfated metabolite of glyceollins with an additional oxygen
(m/z 433) showed B fragments (m/z 148, and 149) were the same as those found for unmetabolized
deprotonated glyceollins, whereas A fragments (m/z 191 and 243) were shifted higher by 16 mass
units. These combined observations allowed the localization of oxygen attachment on
glyceollins.19 For the GSH breakdown products, the appearance of the m/z 149 fragment suggests
that the oxygen and cysteinylglyceine dipeptide or cysteine are not located on the B fragments.
More importantly, the A fragment expected at m/z 2157,19 has been shifted to m/z 231 (Figure 22b), thus indicating that oxygen addition had occurred on the A fragment. Structures of oxygenated
cysteinylglyceine- and cysteinyl- glyceollin conjugates are proposed in Figure 2-2a and 2.2b,
respectively. Based upon our evidence for initial epoxidation followed by GSH attachment,
combined with the CID data presented above, we conclude that there are only four possible
structures for the oxygenated cysteinylglyceine- and cysteinyl- glyceollin conjugates (Scheme
2.2). These assignments of oxygenated cysteinylglyceine (m/z 531 in NI mode) and oxygenated
cysteinyl (m/z 474 in NI mode) glyceollin conjugates were further confirmed by acquiring data in
positive ion mode. Figure 2-3a and 2-3b show the PI mode LC-ESI-MS/MS CID product ion mass
spectra of m/z 533 (protonated cysteinylglyceine glyceollins with an additional oxygen) and m/z
476 (protonated cysteinyl glyceollins with an additional oxygen). The appearance of m/z 355
corresponds to the loss of 178 Da from m/z 533 (Figure 2-3a) and 121 Da from m/z 476 (Figure
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2-3b), indicating a loss of intact cysteinylglyceine or cysteine, respectively, that mirror the losses
observed in the NI mode.
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Cysteine conjugates can be further metabolized and acetylated, resulting in mercapturic
acid conjugates as mentioned above. However, these anticipated conjugates were not detected in
the precursor ion scan of m/z 148. Consequently, screening for mercapturic acid conjugates of
glyceollins was directly performed by product ion scanning. The NI mode LC-ESI-MS/MS CID
product ion mass spectrum of m/z 516 (corresponding to the previously detected m/z 474 cysteinyl
glyceollins with additional oxygen peak that had potentially undergone acetylation) was performed
on rat plasma, urine, and feces samples. Only feces eluted a chromatographic peak corresponding
to m/z 516 that appeared at 22.9 min. The NI mode LC-ESI-MS/MS CID product ion mass
spectrum of the m/z 516 precursor showed a fragment at m/z 353 corresponding to the loss of
mercapturic acid (163 Da) from the oxygenated mercapturic acid conjugates of glyceollins. Other
fragments similar to those in the CID product ion spectrum of deprotonated glyceollins were
detected at m/z 148, 149, and 161; however, the signal for m/z 148 was very low.
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Figure 2-3: LC-ESI-MS/MS product ion spectra of (a) m/z 533 precursor and (b) m/z
476 precursor in positive ion mode.
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2.4.3

Glucuronidation of glyceollins
Because glucuronide conjugates have been reported for isoflavones,41,42,43 the decision was

made to screen for glucuronide conjugates of glyceollins by performing product ion scans. In
general, an addition of 176 Da in biological medium is well documented to be characteristic of
addition of glucuronic acid.28,44 Thus, the LC-ESI-MS/MS CID product ion scan of m/z 513 was
carried out on rat plasma, urine, and feces samples, but a corresponding chromatographic peak
appeared at 27.6 min from rat plasma and urine samples only. The averaged product ion mass
spectrum (Figure 2-4) shows a peak at m/z 337 corresponding to deprotonated glyceollins
production after loss of glucuronic acid. In addition, the highest abundance fragment appears at
m/z 175. Even though a low abundance product ion at m/z 175 had been observed during CID of
deprotonated glyceollins (m/z 337),7,19 the high abundance of m/z 175 in Fig. 5 is better
rationalized as release of glucuronate anion. No fragment ions in Figure 2-4 are shifted by 176
mass units relative to the product ions in the CID spectrum of m/z 337 (deprotonated glyceollins),
indicating that the glucuronide moiety is the most labile substitutent of the m/z 513 precursor.
Other CID product ions are assigned as consecutive decompositions of m/z 337, including m/z 319
(water loss) and m/z 149 production, but m/z 148 is absent. This latter product ion is not always
observed upon consecutive decompositions as it requires relatively high energy CID conditions.19
That is, owing to the energy consumed in decomposing m/z 513 to m/z 337, less energy remains
for m/z 337 to undergo consecutive decomposition, which results in more favorable kinetics for
m/z 149 production relative to m/z 148. This also rationalizes the absence of m/z 513 in the scan
for precursors of m/z 148 spectrum.
Glucuronide conjugates of glyceollins for LC-ESI-MS/MS method development are not
commercially available. Nonetheless, in vitro glucuronidation is often performed with the aid of
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uridine diphosphoglucuronosyl-transferase enzymes (UGTs).45 The UGT enzymes are present in
abundance in rat liver microsomes. Using this approach, rat liver microsomes were treated with
glyceollins to generate glucuronide conjugates of glyceollins. LC-ESI-MS/MS analyses were then
carried out. The retention time and the similar fragmentation pattern in product ion spectrum of
m/z 513 (Figure 2-4b) confirmed our assignment of glucuronidated metabolite of glyceollins from
rat plasma and urine samples.
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Figure 2-4: LC-ESI-MS/MS product ion spectrum of m/z 513 precursor corresponding to
glucuronic acid conjugates of glyceollins acquired from (a) rat urine and (b) rat liver
microsomes.
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2.5

Conclusion

LC-ESI-MS/MS analyses were carried out on a triple quadrupole to identify glyceollins
and their metabolites from rat plasma, urine, and feces. The precursor ion scan of m/z 148 allowed
screening for glyceollin-related compounds. Peaks of interest were found at m/z 474 and 531 in rat
plasma, urine, and feces samples, which were further investigated by product ion scanning.
Tandem mass spectra of m/z 474 and 531 acquired in negative ion mode provided evidence for the
glutathione conjugation pathway. The m/z 474 and 531 were identified as cysteine and
cysteinylglyceine conjugates of glyceollins with an addition of an oxygen, respectively. The
assignments were further confirmed by examining these conjugates in positive ion mode. We
proposed that the formation of these Phase II metabolites is facilitated by epoxide formation (Phase
I metabolism) on glyceollins. Four possible isomeric structures are proposed based upon tandem
mass spectrometry fragmentation patterns. Oxygenated forms of mercapturic acid conjugates of
glyceollins (m/z 516) were found to be present in rat feces, but not in rat plasma or urine. On the
other hand, glucuronide conjugates of glyceollins were detected in rat plasma and urine. The
identification of glucuronide conjugates of glyceollins was confirmed by in vitro glucuronidation
of glyceollins by rat liver microsomes. To our knowledge, this is the first study to establish
glutathione and glucuronide pathways of glyceollin metabolism. Oxygenated and non-oxygentated
forms of cysteinylglycine, cysteine and mercapturic acid conjugates of glyceollins are reported
along with glucuronide conjugates of glyceollins from glyceollin-dosed animals.
The scan for precursors of m/z 148 is thus a powerful method which allowed the
characterization of glyceollin metabolites which may otherwise be difficult to pin-point, such as
the newly reported oxygenated GSH by-product conjugates found here. These GSH by-product
conjugates yielded mostly neutral losses of the peptide portion during tandem mass spectrometry.
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Thus, these conjugates may have been overlooked if they were screened for by use of conventional
product ion scans that rely on the appearance of charged peptide fragments. Because the
appearance of m/z 148 in precursor ion scans requires optimized CID energies, which may vary
according to the particular metabolite, the only caveat to this method is that all metabolites may
not be detected using a single experimental condition (as was the case of mercapturic acid and
glucuronide conjugates in this study).
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CHAPTER 3

ON-LINE THERMAL DESORPTION-GC-MS CHARACTERIZATION OF
MICROBIAL VOLATILE ORGANIC COMPOUNDS DETECTED FROM
SIMULATED FLOODING ENVIORNMENTS AND PRODUCED BY
CHAETOMIUM AND CLADOSPORIUM FUNGI

Syeda S. Quadri, Michael Ferris, Jim Cutler, Richard B. Cole
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3.1

Abstract

Mold infestation is a global problem associated with damp environments. Mold produces
microbial volatile organic compounds (MVOCs) that can vary depending on the implicated fungal
species and the growth substrate. In this paper, the presence of fungi and their MVOC production
was monitored from different simulated flooding environments employing freshwater, brackish,
and saltwater. The MVOCs were analyzed using a modern technology system coupling thermal
desorption on-line with gas chromatography-mass spectrometry (TDA-GC-MS). 1-Undecanol, 2ethylhexanal, and 2-ethylhexanol were found to be present in all simulated flooding environments.
However, no specific pattern in MVOCs production was observed that was dependent on the
salinity. Molecular identification of fungi was also performed and 10 species were identified.
Included in the identified fungi are Cladosporium cladosporioides, Dothideomycetes sp,
Chaetomium murorum, and Fusarium delphinoides that are commonly associated with damp
environments. Guided by the above findings, toxic fungi Chaetomium sp. and Cladosporium sp.
were cultivated on drywall (low nutrient) or potato dextrose agar (PDA, high nutrient) substrates
and MVOCs produced from these fungi were compared to determine the effects of substrate on
MVOC production and to identify novel MVOCs that are indicative of growth for each fungus. 3Furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal were consistently detected in both
growth media for each of the mold species. Thus, we propose these latter two MVOCs as novel
indicators of mold growth for Chaetomium sp. and Cladosporium sp fungi.
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3.2

Introduction

Flooding of human dwellings is a global problem and many uncertainties exist concerning
the assessment of human health risks associated with exposure to consequent mold growth.
Hurricane Katrina struck New Orleans on August 29th 2005, and in the aftermath following
multiple levee breakages, 80% of the city became flooded with water levels as high as 6 m (1).
Approximately 120,000 homes were flooded and some homes remained under water for several
weeks (2). Because of the widespread flooding, there was extensive mold growth in the flooded
areas. A survey conducted by the Centers for Disease Control and Prevention showed that 46% of
randomly selected houses in the New Orleans area had visible mold growth and 17% had heavy
mold contamination (3). As determined by indoor and outdoor air sampling, the predominant mold
species present in the contaminated houses were Aspergillus, Cladosporium, and Penicillium (3,4);
Stachybotrys was also found in some houses (2). This became an immediate concern because
adverse public health effects have been associated with species belonging to these genera.
(2,5,6,7). The adverse health effects include pulmonary, immunologic, neurologic, and oncologic
disorders (5). Various illnesses caused by mold include airway infections, compromised immune
function, bronchitis, asthma, and extreme fatigue (7, 5, 13).
Fungi affect human health through well-defined mechanisms: generation of harmful
immune response, direct infection by the microbe, and toxicity/irritation from by-products (27).
Among the toxic irritants are secondary metabolites that are produced for species protection and
to promote sporulation (8). Secondary metabolites may also be produced during nutrient
deprivation, or in the presence of competing coexisting species or environmental stressors (21).
Secondary metabolites produced by fungi include mycotoxins and volatile organic compounds.
Referred to as microbial volatile organic compounds (MVOCs), these are small-molecules that are
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produced as end products of the metabolism of organic material (9, 21). Elevated amounts of
indoor MVOCs create a potential health hazard to humans (10, 11). While some studies suggest
that there is no correlation between fungal MVOCs and human health, other studies link MVOCs
to an increase in nasal lavage biomarkers, frequent blinking and a decrease in forced vital capacity
(FVC) (12, 13). MVOCs are also associated with “sick building syndrome.” (15) The latter refers
to a ‘higher than normal’ prevalence of symptoms affecting the eyes, head, upper respiratory tract
and skin associated with a particular building (36,37).
Visual mold growth is an obvious indication of the presence of mold. However, only 1020% of the mold in an affected building is typically visible (16). Often mold remains hidden behind
shelves, carpets, wallpaper, wardrobes or covered ceilings. Hidden mold can be detected by
analysis of material collected from surfaces, or by sampling and analysis of MVOCs (16). The
analysis of MVOCs is typically carried out by first capturing MVOCs on an adsorbent using active
or passive sampling. The collected analytes can be extracted from the adsorbent by either classical
solvent extraction or by the newer approach of thermal desorption (29,30). In thermal desorption,
trapped volatiles and semi-volatiles are released from adsorbents by rapid heating with recapture
of the desorbed products on a cold trap. Afterwards, the cold trap is rapidly heated in preparation
for the analysis step. The thermal desorption technique provides the advantage of eliminating the
solvent dilution step of conventional solvent extraction procedures. By avoiding a solvent
extraction step, the extraction efficiency of thermal desorption can approach 100% from porous
polymer or charcoal sorbents (29).
A well-established (39,40) approach for volatile and semi-volatile analysis is the
combination of gas chromatography (GC) separation followed by electron ionization mass
spectrometry (EI-MS) detection. The rapid desorption from the cold trap of a Thermal Desorption
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Analyzer (TDA) is highly compatible with the requirement to introduce all desorbed species onto
the GC column in a narrow band. The powerful combination of TDA-GC-EI-MS is a very
convenient, sensitive and selective approach for trapped volatile and semi-volatile analysis that
has been gaining increasing attention in recent years (22,23).
The combination of TDA-GC-EI-MS has been used to analyze environmental air samples
from various mold growth scenarios. Researchers have proposed that certain MVOCs (mainly
aldehydes, alcohols, ketones, furans and terpenes) can be used as indicators of mold contamination
in indoor environments (21). Chemical markers which have been reliably connected to fungal
growth include 3-methylfuran, octan-3-one, hexan-2-one, heptan-2-one, 1-octen-3-ol, 3-octanol,
and 3-octanone among others (14, 17, 18, 19, 35). The MVOCs 1-octen-3-ol and 3-methylfuran
have been suggested to cause acute irritation to the eyes, throat, and respiratory airways (14,38).
However, much of the MVOC data that can be found in the literature concerning flooded
environments was assessed months after the actual flooding event (18, 22, 23, 24, 25, 28). Other
MVOC analyses have investigated emissions from individually cultivated fungal species that were
usually chosen based on suspected toxicity of the fungus (18, 22, 23, 24, 25, 28).
The study described in this paper uses an integrated two-pronged approach to assess
MVOC production from fungal species appearing in flooded environments. Flooding events
simulating actual flooding conditions in southern Louisiana (using different water salinities) were
carried out in glass containers. MVOC analyses of volatiles and semi-volatiles were performed as
was DNA sequence analysis of visible fungal growth. Toxic fungi identified by DNA sequencing
were then investigated in isolation. MVOCs of cultivated fungi and simulated flood fungi were
compared. The aim of the present study is uncover unique MVOCs of fungi that can serve as
diagnostic MVOCs to establish the type of mold present in damp environments.
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3.3
3.3.1

Method and Materials

Simulated flooded environment
Flooded home simulations were created in one-gallon glass containers. Each container held

a 6 x 4-inch piece of gypsum board that was “flooded” with one liter of either brackish, fresh, or
salt water. Another container was flooded with freshwater to which plant food was added to
investigate the effects of nutrients. Brackish water was obtained from Lake Pontchartrain, LA
(accessed from New Orleans near Elysian Fields Blvd.), whereas freshwater and saltwater were
obtained from the Mississippi River (accessed from Kenner, LA near Williams Blvd.) and Saint
Louis Bay (accessed from Slidell, LA), respectively. The containers were closed with lids and
were set in a greenhouse where temperatures reached above 90 oF during the summer. Four
openings were drilled in the lids of the glass containers for air intake and sampling. A glass tube
filled with glass wool was placed in the air inlet to reduce circulation and to prevent a vacuum
from being created during the air sampling period. The other 3 openings were used to hold sorbent
tubes during air sampling; these openings were closed with cork at all other times.
3.3.2

MVOC sampling of simulated flood chambers
Microbial volatile organic compounds were collected on days zero, four, nine, and

fourteen. Volatile sampling was carried out using AirChek 52 pumps (SKC Gulf Coast Inc,
Houston, TX). Low flows were maintained by a Tri Adjustable Low Flow Holder (Gulf Coast Inc,
Houston, TX). Three sorbent tubes, 4 ½” x 4 mm ID packed with Carboxen 1000, Carbosieve SIII,
and Tenax-TA (CDS Analytical Ins, Oxford, PA), were placed on the lids of each container that
were connected to a pump through the tri-manifold. All samples were collected in triplicate.
Volatile sampling was performed for 60 min at the flow rate of approximately 8.3 mL/min for a
total (calibrated) sampling volume of 0.5 L per tube. The three replicates allowed a total of 1.5 L
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of air to be sampled per container. EPA method TO-17 recommends limiting volumes to 0.5 L per
tube when water is present or to 2 L when there is only high humidity (30). Each time that volatile
sampling was performed, greenhouse air and lab air were also collected to serve as controls.
3.3.3

On-line thermal desorption-gas chromatography-ion trap mass spectrometry
The sorbent tubes used for volatile sampling of the simulated flooded environments were

thermally desorbed at 300 oC for 15 min using a Dynatherm 9300 thermal desorption analyzer
(TDA) (CDS Analytical Inc, Oxford, PA). After recapture on the “trap” of the TDA, this trap was
heated at 310 oC for 5 min to desorb all MVOCs into the transfer line leading to the GC-MS. GC
transfer line and interconnect line temperatures were kept at 300 oC. Helium was used as the carrier
gas at a flow rate of 60 mL/min for thermal desorption. The injection port temperature of the GC
(Varian 450 GC, Walnut Creek, CA) was kept at 250 oC with injections performed in split mode
using an injection ratio of 1/20. The GC carrier gas flow rate was 1.0 mL/min. The oven
temperature was programmed from 40 oC to 250 oC at 8 oC/min with a hold time of 5 min. The
initial hold time of the oven was 2 min. The MS (Varian 240 MS, Walnut Creek, CA) transfer line
temperature was 280 oC. Samples were analyzed in EI mode using 70 eV electron energy. A 2 min
post-injection filament delay was used, during which time no data was acquired on the mass
spectrometer. To qualify as a detected signal, a signal-to-noise ratio of greater than 3 was required
in the obtained EI mass spectrum. The NIST library was used to identify eluted compounds. These
identifications were confirmed by manual interpretation of mass spectra. When the spectrum of
the library did not match closely with the spectrum of the compound detected, the compound was
treated as an unknown. This method is based upon EPA TO-15 (32) with slight modifications.
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3.3.4

Mold collection and identification
Samples of the individual mold colonies that were imbedded on the drywall were obtained

by removing a speck with sterile tweezers. The samples were placed in microcentrifuge tubes.
Fungal DNA was obtained using the commercially available fungal genomic DNA kit
“MasterPureTM Yeast DNA Purification Kit” (Epicenter Biotechnologies, Madison, WI). Genetic
identification of fungal species was performed using polymerase chain reaction (PCR) assays
directed towards a broad range of fungal genera. PCR-amplification with ITS4 and ITS5 primers
was carried out in a thermocycler (BioRad, Hercules, CA). These primers, as described by White
et al. (31), amplify the conserved regions of 28S (ITS 4) and 18S (ITS 5) rRNA genes. Sequences
of primers are as follows: ITS 4, 5’-TCCTCCGCTTATTGATATGC-3’ and ITS 5, 5’GGAAGTAAAAGTCGTAACAAGA-3’. Thermal cycling consisted of 95o C for 4 min, followed
by 30 cycles of 95 oC for 1 min, 52 oC for 1 min, and 72 oC for 1 min, and final extension at 72 oC
for 7 min. The sequencing reaction was performed by Davis Sequencing, Inc (Davis, CA) and
sequence analyses and alignments were carried out using Sequencher Software. The BLAST
algorithm at the NCBI website was used to identify the fungal sequences.
3.3.5

Laboratory cultivation
Two nutrient media were used, either gypsum board (drywall, low nutrient) or potato

dextrose agar (PDA, high nutrient). Gypsum board was selected because it is the most common
wall building material in the New Orleans region, whereas PDA was employed because it is the
most commonly used laboratory medium for cultivation of fungi. Potato dextrose agar plates were
prepared by autoclaving 9.75 g of PDA in 250 mL of deionized water. Drywall plates were made
the same way, except that drywall was pulverized and suspended in the agar. The plates were
cooled and stored at 4 oC until inoculation. Chateomium (M1.903) and Cladosporium (M1.881)
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were separately inoculated on petri plates on both media. The petri plates were stored at 4 oC for
at least one week before inoculation, so that any media gaseous emission would not interfere with
MVOCs sampling. After inoculation, the petri plates were placed in cultivation chambers (onegallon glass containers similar to those used for simulated floods) with four openings on screwtop lids. One opening of each container was fitted with glass wool-packed glass tubes for air
exchange, whereas the other three were closed when sampling was not being performed.
Containers were left to incubate for 20 days before sampling for MVOCs. Volatiles sampling for
these cultivated fungi was carried out in a manner analogous to what was described above for
simulated flooded environments. TDA-GC-EI-MS conditions employed for volatile analyses were
also the same as those used for simulated floods.
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3.4

Results and Discussion

The first part of our study employs simulated flooding environments to investigate mold
growth and MVOCs production over time in the presence of coexisting species. Flood conditions
were simulated by the use of fresh or salt water to investigate the species of mold that proliferate
on gypsum board building material. Gypsum board, commonly known as drywall, is primarily a
source of carbon as well as co-factors such as Ca2+, K+, and other nutrients. Nutrients for mold
growth are usually also present in flood water; moreover, nitrogen fixing bacteria present in the
environment, can provide a source of fixed nitrogen needed for fungal growth. In New Orleans,
flooding of homes by freshwater is common. Such floods are often due to intense rain events that
overwhelm pumping station capacities. In nearby areas, freshwater flooding caused by intense rain
and high river levels is also common. On the other hand, the storm surge associated with hurricane
causes salt water flooding along coastal communities in Louisiana. For this reason, variable
salinity levels were employed in our simulated flooding to probe the effects of salt content on the
variety of mold species that proliferate and the types of MVOCs that are produced in flooded
environments.
3.4.1

PART I: MVOC analyses of simulated flood environments
Statistically significant amounts of MVOCs were detected by Day 4 of sampling. The

variety and quantities of MVOCs were monitored over time. Table 3.1 lists MVOCs detected over
three different sampling periods along with their relative peak areas. The changes in the peak areas
over a two week time period allowed calculation of the temporal variation in concentration of each
MVOC. No visible mold growth was observed during the two week period; however, MVOC data
indicates that mold growth activity was occurring. A few of the detected and identified MVOCs
have been reported in the literature as mold indicators, such as
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Type of flooding

River (freshwater)

Bay (salt water)

Lake (brackish)

environment
Time of MVCOs

Day 4

Day 9

Day 14

Day 4

Day 9

Day 14

Day 4

Day 9

Day 14

nd

sampling (days)
Peak areas given in arbitrary units

MVOCs
3-Furaldehyde
2,2-diethyl-3-

7.0x10

7

nd

nd

5.6x10

6

nd

nd

1.3x106

1.0x107

methyloxazolidine
I-Undecanol
3-Hexen-2,5-diol
4-Methoxy-4-

4.9x106
nd
2.5x10

7

nd

3.4x10

nd

nd

4.5x106

nd

1.2x107

5.1x106

nd

nd

2.7x107

6

vinylphenol
2-Ethylhexanal

1.1x107

7.4x105

2.4x106

1.4x107

8.0x105

1.4x107

2-Ethylhexanol

5.4x10

5

6

7

7

5

7

Vanillin

2.7x107

8.9x10
nd

1.0x10

3.0x10

8.5x10

4.3x10

nd

7

3.2x107

2.9x106

1.5x106

1.3x106

1.4x107

8.7x106

1.0x107

nd

3.0x107

nd

9.2x10

7

5.2x10

nd

4-

nd

nd

x

Phenylcyclohexene
5.3x106

1-(2methylpropyl)cyclohexene
3-Heptanone
2-Methyl-3-

6.9x105

nd

2.8x105

8.1x106

3.5x106

7.5x106

1.0x107

nd

7.1x106

nd

nd

9.9x106

nd

nd

7.8x106

nd

nd

1.1x105

hydroxy-2,4,4trimethylpentyl
ester

propanoic

acid
Thujopsene-13
3-Heptanol
3-(4-hydroxy-5-

7

nd

nd

2.2x105

nd

nd

4.0x10

methoxyphenyl)-2propenal
2-Heptanone

Table 3-1: Peak areas of MVOCs found from freshwater, salt, and brackish water simulated
floodings. “nd” indicates not detected.
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2-heptanone,

2-ethylhexanol,

and

1,1a,4,4a,5,6,7,8-octahydro-2,4a,8,8,tetramethyl-

,(1aS,4aS,8aS)-(-)-cyclopropana[d]naphthalene (thujopsene). (23) While some MVOCs unique to
each environment were noted, many MVOCs were observed consistently in 2 of the 3 flooding
conditions or even in all 3 of the flooding conditions. 2-Ethylhexanal, 2-ethylhexanol, 1undecanol, 2-Methyl-3-hydroxy-2,4,4-trimethylpentyl ester propanoic acid were common to all
three flooding conditions. By contrast, thujopsene was detected from freshwater and saltwater
simulated flooding, whereas 3-heptanol was detected from saltwater and brackish water flooding.
Thujopsene-13 was not detected from either medium until day 14, while 3-heptanol was detected
on day 9 from brackish and day 14 from saltwater flooding in high abundance. Some of the
freshwater MVOCs were also detected from the saltwater and brackish water, but many more
MVOCs were detected from freshwater simulated flooding. 4-phenylcyclohexene and 3-heptanone
were specific to saltwater, whereas 1-(2-methylpropryl)-cyclohexene was found only in brackish
water. On the other hand, 3-furaldehyde, 2,2-diethyl-3-methyloxazolidine, vanillin, 3-(4-hydroxy5-methoxyphenyl)-2-propenal, and 2-heptanone were specific to freshwater simulated flooding.
From the above mentioned MVOCs, thujopsene and 2-ethyl-1-hexanol are MVOCs
produced by Stachybotrys chartarum (23). In particular, 2-ethyl-1-hexanol was reported to be
readily produced by Stachybotrys chartarum on drywall board cultures (23). The detection of these
two compounds in the freshwater flooded environment suggests the presence of Stachybotrys
chartarum under these flooding conditions. 2-Heptanone, which is often reported as a mold growth
marker, was only detected from freshwater MVOC sampling. It is reported to produced by
Aspergillus sp, Penicillium sp., Eurotium sp, Chaetomium globosum, and Cladosporium
cladosporoides (9,14,25,26). Thus, it is likely that one or more of these species is present in the
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freshwater simulated flooding environment. Our results also suggest that the freshwater
environment allows proliferation of many coexisting species as compared to higher salinity
conditions. Because mold growth was not visible to the naked eye by day 14 of simulated flooding,
we consider MVOC analysis to be a more effective approach for monitoring the start of mold
growth activity.
3.4.2

PART II: Molecular identification and MVOC results and discussion
Research has shown that the use of PCR-amplification and DNA sequence analysis of

fungal internal transcribed spacer (ITS) regions provides a highly complete and accurate
assessment of fungi present in natural specimens (33,34). For this reason, the PCR-amplification
DNA sequencing approach was used in our study. Mold appearing in colonies was scraped from
above the "water line" in each of the three simulated flood environments. Samples for molecular
identification were taken on days 40 and 70. The sequencing results suggested mixed populations
of fungi were present. Mixed populations were observed from every simulated flood environment.
The sequencing data of the first fungal colony sampling (day 40) indicate that the freshwater
flooded environment had Cladosporium cladosporioides and Toxicocladosporium irritans
colonies. Drywall flooded with the brackish water showed Helotiales sp. growth along with an
unknown fungus which did not match any sequence from BLAST. While Cladosporium genus
was detected from freshwater flooding, other expected molds such as Aspergillus, Penicillium, and
Stachybotrys were not observed. It was surprising to see that sampling results showed no
appearance of the most predominantly reported mold species associated with damp buildings, i.e.,
Aspergillus and Penicillium (2-7). Linking these identifications to the findings in Part 1, the
detection of 2-heptanone can be attributed to the presence of Cladosporium cladosporoides in
freshwater flooding.

65

At the second fungal sampling (day 70), Dothideomycetes sp was predominantly found
from both brackish and freshwater flooding. Regardless of salinity, the fact that one predominant
species (Dothideomycetes sp) was observed after 2 months suggests that it utilizes the available
resources effectively, hence, it proliferates even when nutrients are scarce. Dothideomycetes sp
are known to effectively degrade biomass and contribute to the carbon cycle (45). They are also
tolerant of extreme environments such as heat, humidity, and cold (46). Because the experiment
lasted for over two months, a diminishing amount of nutrients remained present in the containers
over time. Since Dothideomycetes sp is capable of fixing its own carbon source and can survive
harsh conditions, this may account for its advantage in proliferating over other species.
A simulated flood of freshwater, to which plant food (with additional nutrients) was added,
showed considerably more fungal species on the second fungal sampling (day 70) compared to
plain freshwater which showed considerably less visible mold. When searching the BLAST
database, our obtained sequencing data of the first fungal sampling (day 40) identified the presence
of Cladosporium cladosporioides, Cochliobolus lunatus and Dothideales sp., whereas the second
fungal sampling results (day 70) identified Scedosporium dehoogii, Chaetomium murorum,
Fusarium delphinoides, Cochliobolus lunatus, and an unknown. . Importantly, Cladosporium
cladosporioides, Chaetomium murorum and Fusarium delphinoides are toxigenic molds that have
been associated with human health risk. Chaetomium sp. can cause onychomycosis, peritonitis,
empyema, pneumonia, and invasive/cerebral disease in immuno-compromised persons (41).
Fusarium sp. has been linked to allergies, wounds and infections of the eyes and fingernails,
invasive mycoses, inhalation and deep skin incisions to people with weak immune systems (42).
Cladosporium sp. are known to cause ergotism and chronic hypersensitivity pneumonitis (HP)

66

(43). The sources of these fungal species found in BLAST were soil, water, or moldy paint. These
results suggest that in the presence of more available nutrients, many fungal species can coexist.
MVOC sampling was performed prior to each colony sampling for fungal sequencing. The
MVOCs detected from the freshwater simulated flooding with added nutrients (day 40) include 2hexen-1-ol,

cyclohexanone,

2,2,6-trimethylcyclohexanone,

octanal,

and

2,5-

diphenylbenzoquinone. Wilkins et al. (22) found octanal in the dust and material obtained from a
moldy building, but it was not detected in their air sampling. In the current study, octanal was
detected from the air of the freshwater simulated flood. Cyclohexanone has been reported to be
produced by Cladosporium cladosporioides, Aspergillus versicolor, A. niger, A. fumigatus, and
Penicillium expansum (26). As mentioned above, the genetic sequencing data shows the presence
of Cladosporium cladosporioides. Thus, cyclohexanone could have been produced by
Cladosporium cladosporioides. While day 40 showed the presence of several MVOCs from
freshwater simulated flooding with added nutrients (plant food), no significant amounts of MVOCs
were detected on day 70. Furthermore, significant amounts of MVOCs were not detected from
other simulated environments for either sampling period. The number of MVOCs detected at the
later stage (days 40 and 70) of flooding was much lower than that detected at the earlier stage (days
4-14). This may be a reflection of the diminishing availability of nutrients as time progressed,
causing a decrease in mold growth and associated MVOC production.
Another volatile sampling was performed 4 months (day 120) after the simulated flooding.
Although mold growth was visible, no MVOCs were detected in any of the simulated flood
environments. These results were in accordance with the first set of simulated flooding results (day
70). Many cultivation studies propose that the largest amounts of MVOCs are produced at the
beginning of cultivation (9). Mold undergoes exponential growth for 3 days after inoculation and
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then switches its metabolism to idiophase (stationary phase) to produce spores and MVOCs. Much
of the cultivation medium is consumed in 15 days (9), so MVOC production decreases. This may
be the case in the simulated flood where over time, fungi proliferate and eventually a nutrient
deficiency occurs. At that point, mold can no longer undergo idiophase metabolism to produce
MVOCs.
3.4.3

PART III: MVOCs detected from cultivation of fungi
Cladosporium sp. and Chaetomium sp. fungi were chosen for cultivation since they were

found in simulated floods and they are often associated with damp environments. Several volatiles
were detected from the Chaetomium sp. and Cladosporium sp. growth cultivated in nutrient-rich
medium (PDA) and low nutrient medium (drywall) including several alcohols, aldehydes, ketones,
and furans that have been suggested to be mold growth indicators. Table 3.2 shows the complete
list of volatiles found from the two species on both growth media.
MVOCs observed from Chaetomium sp cultivated on the nutrient-rich medium include 3octanol, 3-octanone, 3-furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal. The last two
MVOCs mentioned were consistently observed from both Chaetomium sp. and Cladosporium sp.
regardless of the substrate. Chaetomium genus, and in particular Chaetomium globosum produce
3-octanone and 3-octanol that are commonly associated with mold growth (9). However, the latter
two common mold growth indicators were not detected from drywall medium. Tiebe et al. (24)
and Matysik et al. (26) each detected production of 3-octanone from cultivation of fungi on
nutrient-rich media DG 18 agar and malt extract agar (MEA), respectively, along with many other
MVOCs. Gao and Martin (23) compared the production of 3-octanone from gypsum board with
MEA and reported its occurrence from MEA medium only. The absence of 3-octanone from low
nutrient media thus seems general, and it indicates that this volatile is more likely to appear when
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mold proliferates in a nutrient-rich environment. For this reason, 3-octanone may not be a good
‘global’ mold growth indicator in all environments.
In comparison with Chaetomium sp., Cladosporium sp. produced a greater number
of volatile organic compounds on the nutrient rich medium. The MVOCs produced by
Cladosporium included several aldehydes, ketones, furan, nitrogen containing compounds and a
few unknowns (see Table 3.2). MVOC 3,3,5-trimethylcyclohexanone was of particular interest
since its isomer 2,2,4-trimethylcyclohexanone was detected from the freshwater simulated
flooding with added nutrients. As mentioned above, the genetic sequencing data showed that one
of the species found from freshwater simulated flooding with added nutrients was Cladosporium
cladosporioides. The detection of one of two trimethylcyclohexanone isomers from either the
simulated flooding with added nutrients or cultivation of Cladosporium sp. on PDA medium
suggests that fungi produce certain unique volatiles when provided with nutrient-rich
environments. Because neither trimethylcyclohexanone isomer was detected from the drywall
medium, they cannot be used as biomarkers for Cladosporium sp. This underscores the fact that
production of MVOCs is strongly dependent on the available nutrients.
MVOCs found from Chaetomium sp. growth on low nutrient medium include styrene, 3furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal along with 3-pyridinol and 2,2diethyl-3-methloxazolidine; the latter two contain nitrogen. 3-furaldehyde and 3-(4-hydroxy-3methoxyphenyl)-2-propenal were also detected from Cladosporium sp. growth on low nutrient
medium. Amine containing volatiles were not detected, but every MVOC that was detected from
Cladosporium sp. growth on low nutrient medium was also observed from nutrient-rich medium.
The absence of many volatiles from Chaetomium sp. growth on low nutrient medium as compared
to nutrient-rich medium (see Table 3.2) indicates again that the production of MVOCs is highly
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dependent on the growth substrate. Other studies have also mentioned that specific MVOC
production changes with the medium (20,23,25). Styrene has been reported as a MVOC produced
by Penicillium and Trichoderma (20, 25). The results of our study show that styrene is also
produced by Chaetomium even in a nutrient-deprived environment.

Table 3-2: List of MVOCs produced by Chaetomium sp. and Cladosporium sp. on PDA and
drywall media. “nd” indicates not detected
Microbial Volatile Organic Compounds

Chaetomium
PDA

Drywall

Cladosporium
PDA

Drywall

Peak areas given in arbitrary units
3-furaldehyde

7.18x106

2.24x106

1.12x107

4.38x106

3-(4-hydroxy-3-methoxyphenyl)-2-propenal

1.02x107

2.97x106

2.81x107

6.37x106

3-Octanone

1.54x106

nd

1.31x10

3-Octanol

nd

2,2-diethyl-3-methloxazolidine

6

7.90x106

5.26x106
1.02x106

3,3,5-Trimethylcyclohexanone
3-Pyridinol

nd

2.24x106

Styrene

nd

7.62x106

1.94x106

Vanillin

8.41x106

2-Furanmethanol

9.85x105

Unknown M+. 162

1.19x107

Unknown M+. 114

1.17x107

70

4.55x106

No MVOC could be called a biomarker of either Cladosporium sp. or Chaetomium sp.
because no single volatile was detected from the same fungus grown on both media. Nonetheless,
3-furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal were consistently observed from
either growth medium for both of the mold species. Figures 3-1 and 3-2i show the electron
ionization mass spectra of these MVOCs along with the NIST library match. The spectra were also
manually interpreted to confirm the MVOCS. Figure 3-3 and 3-4 show the decomposition
mechanism of 3-furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal, respectively. Many
substituted furans and substituted propenals have been detected from damp buildings, but to our
knowledge these two compounds have not been reported as mold MVOCs in the literature. We
thereby propose 3-furaldehyde and 3-(4-hydroxy-3-methoxyphenyl)-2-propenal as novel
indicators of mold growth of Chaetomium sp and Cladosporium sp fungi.

Figure 3-1: EI Mass spectra of 3-furaldehyde. Top spectrum is obtained from MVOC sampling
of cultivated fungal species. Bottom spectrum is the NIST library match of 3-furaldehyde.
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Figure 3-2: EI mass spectra of 3-(4-hydroxy-3-methoxyphenyl-2-propenal. Top spectrum
is obtained from MVOC sampling of cultivated fungal species. Bottom spectrum is the
NIST library match of 3-(4-hydroxy-3-methoxyphenyl-2-propenal.
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Figure 3-3: Decomposition mechanism of 3-furaldehyde.
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3.5

Conclusion

TDA-GC-MS analyses were carried out to identify MVOCs from fungi that coexist in
simulated flooding environments, as well as from fungi cultivated in isolation that were identified
in these simulated flooding environments. High abundances of MVOCs were detected in the early
stages (between days 4-14) of simulated flooding, even when no fungal growth was visible to the
naked eye. This strongly suggests that MVOCs are produced when fungi are actively proliferating.
By Day 40, and continuing afterwards, no significant amounts of MVOCs were detected from
saltwater, brackish, and freshwater flooding environments even though mold was visible in all
simulated environments. The salinity of the flood water did not show a clear correlation with
production of a specific type of MVOC.
Low abundances of MVOCs were found on Day 40 only from the freshwater flooding
environment to which plant food was added. Furthermore, in this latter nutrient-rich environment
only, the continuous presence of several fungal colonies was observed even at Day 70, suggesting
that when nutrients are available, a greater number of fungal species continue to grow. Notably,
no MVOCs were detected from any environment on Day 70 or Day 120. These results clearly
demonstrate that the decrease in MVOC production over time is highly dependent on fungal
growth stage. Another temporal aspect of mold growth that was deduced from molecular
identification data, was the change in the number of species present. After 40 days of flooding,
multiple fungal species were identified, but at Day 70, one species was found to be dominant
(Dothideomycetes sp.) in freshwater and brackish water simulated flooding.
Cultivation data from Chaetomium sp. and Cladosporium sp indicate the production of a
higher number of MVOCs on PDA compared to dry wall. Not all MVOCs that are produced under
the former nutrient-rich environment are produced on the latter low-nutrient environment. The
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MVOCs of particular interest to us that were detected from simulated flooding include 2heptanone,

3-furaldehyde,

2,2-diethyl-3-methyloxazolidine,

and

3-(4-hydroxy-5-

methoxyphenyl)-2-propenal. 2-Heptanone is notable because it has been previously proposed as a
mold growth indicator and it is produced by several toxic fungi including Cladosporium
cladosporioides. The latter fungus was shown by genetic sequencing data to be present in the
freshwater flooding with added nutrients environment along with other mold species. MVOC
sampling from this environment showed the presence of 2-heptanone that was likely produced by
Cladosporium cladosporioides.
Other MVOCs 3-furaldehyde, 2,2-diethyl-3-methyloxazolidine, and 3-(4-hydroxy-5methoxyphenyl)-2-propenal were observed from the freshwater simulated environment (where
Cladosporium sp was detected) and from cultivation of Cladosporium sp. and Chaetomium sp. 3Furaldehyde and 3-(4-hydroxy-5-methoxyphenyl)-2-propenal were consistently observed from the
freshwater flooding environment, as well as PDA and drywall cultivation of both Cladosporium
sp. and Chaetomium sp. By contrast, 2,2-diethyl-3-methyloxazolidine was detected only from
freshwater flooding, Cladosporium sp cultivated on PDA and Chaetomium sp. cultivated on
drywall. Because 2,2-diethyl-3-methyloxazolidine was not detected from all media, it cannot be
used as a reliable biomarker for these fungi. On the other hand, 3-furaldehyde and 3-(4-hydroxy5-methoxyphenyl)-2-propenal that were consistently observed from Cladosporium sp. and
Chaetomium sp. when grown in isolation, can serve as indicators of Chaetomium or Cladosporium
growth.
The use of TDA-GC-MS for MVOC detection is a convenient method to identify the
presence of fungi in moldy buildings especially because this technique has the advantage of
detecting hidden fungal growth. MVOC analyses and genetic identification using PCR
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amplification are two complementary methods. PCR amplification and sequencing is time
consuming, but it is a reliable method for identifying the type of mold present when mold is visible
to the naked eye. On the other hand, MVOC analysis leads to a more rapid indication of fungal
species at an earlier stage of development (i.e., even before mold growth becomes visible)
compared to cultivation or sequence analysis.

76

3.6

References

1. Knabb, R.D., Rhome, J.R., and Brown, D.P., 2005. NOAA National Hurricane Center. 20 Dec.,
2005.
2. Solomon, Gina M.; Hjelmroos‐ Koski, Mervi; Rotkin‐ Ellman, Miriam; Hammond, S.
Katharine. Environmental Health Perspectives (2006), 114(9), 1381‐ 1386.
3. Centers of Disease Control and Prevention. MMWR. Morbidity and mortality weekly report
(2006), 55(2), 41‐ 4.
4. Ratard, R., Brown, CM, Ferdinands, J., Callahan, D., Dunn, KH, Scalia, MR, et al. Morbidity
and Mortality Weekly Report (2006), 55:2, 41‐ 44.
5. Ashraf, Hossain; Sotohy, Ahmed; Afif, G. The Journal of allergy and clinical immunology
(2004), 113(2), 200-8; quiz 209.
6. Miller, J. David; Rand, Thomas G.; Jarvis, Bruce B. Medical Mycology (2003), 41(4), 271-291.
7. Nielsen, K. F. Fungal Genetics and Biology (2003), 39, 103‐ 117.
8. Vining, Leo C. Annual Review of Microbiology (1990), 44, 395-427.
9. Tiebe, Carlo; Huebert, Thomas; Koch, Bernhard; Ritter, Uwe; Stephan, Ina. International
Journal for Ion Mobility Spectrometry (2010), 13(1), 17-24.
10. Wallace L, Nelson W, Ziegenfus R, et al. (1991) The Los Angeles TEAM Study: personal
exposures, indoor outdoor air concentrations, and breath concentrations of 25 volatile organic
compounds. Journal of Exposure Analysis and Environmental Epidemiology 1: 157–192.
11. Kinney PL, Chillrud SN, Ramstrom S, Ross J, and Spengler JD (2002) Exposures to multiple
air toxics in New York City. Environmental Health Perspectives 110: 539–546.
12. Walinder R, Norback D, Wessen B, and Venge P (2001) Nasal lavage biomarkers: effects of
water damage and microbial growth in an office building. Archives of Environmental Health 56:
30–36.
13. Walinder R, Ernstgard L, Johanson G, Norback D, Venge P, and Wieslander G (2005) Acute
effects of a fungal volatile compound. Environmental Health Perspectives 113: 1775–1778.
14. Elke K, Begerow, Oppermann H, Kramer U, Jermann E, and Dunemann L (1999)
Determination of selected microbial organic compounds by diffusive sampling and dualcolumn
GC-FID – a new feasible approach for the detection of exposure to indoor mould fungi? Journal
of Environmental Monitoring: JEM 1: 445–452.
15. Ahearn DG, Price DL, Simmons R, Noble-Wang J, and Crow SA (2004) Indoor moulds and
their associations with air distribution systems. Advances in Applied Microbiology 55: 113–138.
16. Tiebe, Carlo; Miessner, Hans; Koch, Bernhard; Huebert, Thomas. Analytical and Bioanalytical
Chemistry (2009), 395(7), 2313-2323.
17. Bjurman, Jonny; Nordstrand, Erik; Kristensson, Jan. Indoor Air (1997), 7(1), 2-7.
18. Wilkins, K.; Nielsen, E. M.; Wolkoff, P. Indoor Air (1997), 7(2), 128-134.
77

19. Nilsson, T.; Larsen, T. O.; Montanarella, L.; Madsen, J. Oe. Journal of Microbiological
Methods (1996), 25(3), 245-255.
20. Fiedler, Klaus; Schutz, Edgar; Geh, Stefan .
Environmental Health (2001), 204(2-3), 111-121.

International Journal of Hygiene and

21. IOM, Damp indoor spaces and health, Institute of Medicine, National Academy of Sciences.
2004, Washington, D.C.: National Academy Press.
22. Wilkins, K.; Nielsen, E. M.; Wolkoff, P. Indoor Air (1997), 7(2), 128-134.
23. Gao, Pengfei; Martin, Jennifer.
Hygiene (2002), 17(6), 430-436.

Applied

Occupational

and

Environmental

24. Tiebe, Carlo; Huebert, Thomas; Koch, Bernhard; Ritter, Uwe; Stephan, Ina. International
Journal for Ion Mobility Spectrometry (2010), 13(1), 17-24.
25. Matysik, Silke; Herbarth,
Methods (2008), 75(2), 182-187.

Olf;

Mueller,

Andrea.

Journal

of

Microbiological

26. Matysik, Silke; Herbarth, Olf; Mueller, Andrea. Chemosphere (2009), 76(1), 114-119.
27. Bush Robert K; Portnoy Jay M; Saxon Andrew; Terr Abba I; Wood Robert A. The Journal of
allergy and clinical immunology (2006), 117(2), 326-33.
28. Polizzi, Viviana; Delmulle, Barbara; Adams, An; Moretti, Antonio; Susca, Antonia; Picco,
Anna Maria; Rosseel, Yves; t'Kindt, Ruben; Van Bocxlaer, Jan; De Kimpe, Norbert; et al Journal
of Environmental Monitoring (2009), 11(10), 1849-1858.
29. Woolfenden, Elizabeth; Broadway, Graham Special Publication - Royal Society of
Chemistry (1992), 108(Clean Air Work), 207-9
30. Kern, H.; Kirshen, N. A. Special Publication - Royal Society of Chemistry (1992), 108(Clean
Air Work), 210-12
31. White, Thomas J.; Bruns, Tom; Lee, S.; Taylor, J. Edited by Innis, Michael A. PCR Protocols.:
A Guide to Methods and Appl. (1990), 315-22.
32. Compendium of Methods for the Determination of Toxic Organic Compounds in Ambient Air.
Center for Environmental Research Information. Office of Research and Development. U.S.
Environmental Protection Agency. Cincinnati, OH 45268. January 1999
33. Relman, D. A. 2002. Mining the natural world for new pathogens. Am J Trop Med Hyg 67:
133-4
34. Relman. D.A. 2002. The human body as microbial observatory. Nat Gent 30: 131-3
35. Sunesson, Anna-Lena; Nilsson, Carl-Axel; Andersson, Barbro; Blomquist, Goeran. Annals of
Occupational Hygiene (1996), 40(4), 397-410.
36. Hodgson M J; Morey P; Leung W Y; Morrow L; Miller D; Jarvis B B; Robbins H; Halsey J F;
Storey E. Journal of occupational and environmental medicine / American College of Occupational
and Environmental Medicine (1998), 40(3), 241-9.
78

37. Johanning E; Biagini R; Hull D; Morey P; Jarvis B; Landsbergis P. International archives of
occupational and environmental health (1996), 68(4), 207-18.
38. Walinder, Robert; Ernstgard, Lena; Norbaeck, Dan; Wieslander, Gunilla; Johanson, Gunnar.
Toxicology Letters (2008), 181(3), 141-147.
39. Nguyen T L; Gruenke L D; Castagnoli N Jr. Journal of medicinal chemistry (1979), 22(3), 25963.
40. Fischer S; Weber P C. Biomedical mass spectrometry (1985), 12(9), 470-6.
41. Barron MS, Sutton DA, Veve R, Rinaldi M, Thompson E, Cagnoni PJ, Madinget NE.
Interscience Conference on Antimicrobial Agents and Chemotherapy. 2002 Sep 27-30; abstract
no. M-870.
42. Kimura, M.; Tokai, T,; Takahashi-Ando, N.; Ohsato, S.; Fujimura, M.; Bioscience,
Biotechnology, and Biochemistry. Vol. 71 (2007), No 9 pp 2105-2123.
43. Chiba S, Okada S, Suzuki Y, Watanuki Z, Mitsuishi Y, Igusa R, Sekii T, Uchiyama B. Internal
Med. 2009;48(5):363-7.

79

APPENDIX A
A.1
A.1.1

Mercapturic Acid Conjugates of Glyceollins

Oxygenated mercapturic acid conjugates of glyceollins

Figure A-1: LC-ESI-MS/MS product ion spectrum of m/z 516 precursor in negative ion
mode
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A.1.2

Mercapturic Acid conjugates of glyceollins

-MS2 (500.00) CE (-50): Exp 1, 29.121 to 29.582 min from Sample 17 (feces, MS2 500, 516) of Rat Metabolomics.wiff (Turbo Spray)
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Figure A-2: LC-ESI-MS/MS product ion spectrum of m/z 500 precursor in negative ion mode
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APPENDIX B

B.1

B.1.1

MVOC Analysis Setup

Experimental Setup

Figure B-1: Schematics of Air Sampling Setup
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B.1.2

Photos of drywall fungal growth

Figure B-2: Pictures of drywall obtained at the end of the experiment from (1) freshwater
(2) brackish water and (3) freshwater with added plant food simulated flooding
enviornments.
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PDA media. The list of the PDA growth volatiles is mentioned in table _

Eluting Time
S/N ratio
5.807
68
6.392
3
B.1.3
Photos
of
lab
cultivated
-3-one
7.592
7 fungi
he
PDA growth volatiles
lidine
9.206 is mentioned
10 in table _
B.1.3.1 Cladosporium sp.
ne
9.898
24
one
10.089
5
11.067
5
eDS/N ratio 12.626
19

henyl)-2-

68
3
7
10
24
5
5
19

17.920
21.609

5
22

Figure B-3: Cladosporium sp. growth on PDA (left) and drywall (right) media after

5
22

20 days of cultivation.

B.1.3.2 Chaetomium sp.
.

Figure B-4: Chaetomium sp. growth on PDA (left) and drywall (right) media after
20 days of cultivation
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B.2

Gel Electrophoresis

Figure B-5: Stained gel photograph taken after the whole cell PCR of fungal samples
that were obtained on Day 70 of the simulated flooding.
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B.3

El-Mass Spectra and Decomposition Mechanisms

3,3,5-trimethylcyclohexanone

B.3.1

Mass Spectrum and Decomposition mechanism of 3,3,5-Trimethycyclohenanone
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B.3.2

Mass Spectrum and Decomposition mechanism of 2,26-Trimethycyclohenanone
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m/z 41

B.3.3 Decompostion Mechanism of 3-octanol
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